Immunogenicity and Safety of COVID-19 Vaccine in People Living With HIV
Clinical trial NCT05085145 · UNKNOWN
Trial details
- NCT number
- NCT05085145
- Sponsor
- Beijing 302 Hospital
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-01
- Primary completion
- 2022-09-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.